Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Betaseron: a breakthrough treatment for multiple sclerosis

W Morrison1, J Nelson

  • 1Vancouver Hospital, B.C.

The Canadian Nurse
|October 1, 1996
PubMed
Summary

Multiple sclerosis (MS) is a common autoimmune disorder causing disability in young adults. While previously incurable, recent advancements offer new hope for effective treatment of this central nervous system condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toxicity and exposure of an adenovirus containing human interferon alpha-2b following intracystic administration in cynomolgus monkeys.

Gene therapy·2011
Same author

CCDC22: a novel candidate gene for syndromic X-linked intellectual disability.

Molecular psychiatry·2011
Same author

Translational, rotational, and vibrational coupling into phase in diffractively coupled optical cavities.

Optics letters·2011
Same author

Activity classification using a single chest mounted tri-axial accelerometer.

Medical engineering & physics·2011
Same author

Detection of la-1 oncogene in paraffin-embedded cervical-cancer tissues by polymerase chain-reaction.

International journal of oncology·2011
Same author

Widespread divergence between incipient Anopheles gambiae species revealed by whole genome sequences.

Science (New York, N.Y.)·2010

Area of Science:

  • Neurology
  • Immunology
  • Autoimmune Disorders

Background:

  • Multiple sclerosis (MS) is a leading cause of neurological disability among young adults.
  • It is a chronic, demyelinating autoimmune disorder affecting the central nervous system.
  • MS prevalence in Canada is 1 in 1,000 individuals.

Purpose of the Study:

  • To highlight the recent advancements in treating multiple sclerosis.
  • To underscore the significance of new therapeutic options for this debilitating condition.

Main Methods:

  • Review of recent clinical trials and therapeutic developments in MS.
  • Analysis of epidemiological data on MS prevalence.

Main Results:

  • Recent breakthroughs indicate the availability of effective treatments for MS.
  • These advancements mark a significant shift from the previously incurable nature of the disease.

Conclusions:

  • The landscape of multiple sclerosis management is evolving with new therapeutic options.
  • These developments offer improved prognoses for individuals affected by MS.

Related Experiment Videos